Admescope Is A Preclinical Contract Research Organizationcrothat Specializes In Adme Tox Serviceswhich Encompass Absorptiondistributionmetabolismexcretionand Toxicity Studiesfounded In 2011 And Operating Under The Brand Of Symeres Finland Oy Since 2020Admescope Provides Integrated Drug Discovery And Development Servicesincluding Medicinal Chemistrythrough The Symeres Network The Company Offers A Variety Of Services Tailored To The Pharmaceuticalbiotechnologyand Veterinary Industriesthese Include In Vitro And In Vivo Drug Metabolism Studiesdrug Drug Interaction Assessmentsquantitative Bioanalysisand Comprehensive Study Consultingadmescope S Experienced Teamled By Ceo Drouti Kontkanenensures That Research Is Customized To Meet Specific Client Needsoptimizing Conditions For Each Compound With A Diverse Client Base Across Over 30 Countriesadmescope Is A Preferred Partner For Organizations Seeking Specialized Preclinical Research Servicesthe Company S Commitment To Advancing Scientific Knowledge Is Reflected In Its Contributions To Over 300 Scientific Publications
